Detailed results of the phase III CLARINET study at the European Cancer Congress 2013 on 28 September 2013

This article or press release has no online content. Please download the associated documents for more information.

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2019